News & Events

CyberKnife Testimonial: Prostate Cancer Patient

At Columbus CyberKnife, we believe one of the best ways to learn about CyberKnife® treatment is hearing from patients who have been through the treatment process. Prostate cancer patient, Vergil F., was treated at another center with CyberKnife technology.

Unlike conventional surgery for prostate cancer, which can last over three hours, requires general anesthesia and a 3-day hospital stay, CyberKnife can treat prostate cancer patients in five or fewer treatment sessions, without incision or sedation, allowing patients to return to their normal activities following treatment.

View the video below to learn more about Vergil’s experience.

This is not intended as medical advice to replace the expertise and judgment of your health care team. It is intended to help you and your family make informed decisions, together with your doctor.

Patient Support: Influential Prostate Cancer Bloggers

Often, the best insights for patients and families seeking support for a prostate cancer diagnosis come from survivors and others who have experienced the disease firsthand. Online blogs have become a valuable resource for patients who wish to connect to others in the cancer community for advice and emotional support.

We have identified a few influential bloggers who have used their blog as a platform to provide inspiration for prostate cancer patients and their families.

  • Gabe Canales – Only 35 when he was diagnosed with prostate cancer, Gabe Canales was in the midst of his diagnosis when he founded the non-profit group Blue Cure Foundation, whose mission is to save lives by providing prostate cancer education for all men, young and old. Now a survivor and a passionate cancer-prevention advocate, he is a blogger at the Huffington Post where he covers the latest in prostate cancer treatment and prevention.
  • Prostate Diaries – As a prostate cancer survivor and private practice urologist, Dr. John McHugh offers medical insight into the disease, details treatment options and shares personal experiences all with a good dose of humor along the way through his blog.
  • Prostate Cancer - Our Journey – When Daniel Sencier was first diagnosed with prostate cancer in June 2010, he created his blog as a means of keeping his family and friends informed of his process. Four years on, the blog has turned into an engaging diary of Daniel’s life beyond cancer.

This is not intended as medical advice to replace the expertise and judgment of your health care team. It is intended to help you and your family make informed decisions, together with your doctor.

American Cancer Society: 2014 Cancer Statistics

Prostate cancer accounts for about 1 in 6 newly diagnosed cancers each year among men in the United States. In 2014, an estimated 233,000 new cases of prostate cancer will be diagnosed in the U.S. The American Cancer Society estimates that more than 8,690 Ohio men will face a prostate cancer diagnosis this year.

Each year the American Cancer Society releases updated facts and figures highlighting trends and forecasts in the cancer industry. Our presentation below contains the American Cancer Society’s 2014 cancer statistics highlighting predictions of cancer incidence.

Prostate cancer is one of Columbus CyberKnife’s most frequently treated diseases. Contact us to discuss CyberKnife® as a treatment option if you or a loved one has been diagnosed with prostate cancer.

This is not intended as medical advice to replace the expertise and judgment of your health care team. It is intended to help you and your family make informed decisions, together with your doctor.

Understanding the Stages of Cancer

9391512561_518c3f1b6d_oDetermining the stage of cancer is a very important step after someone is diagnosed with cancer. Staging is used to describe the extent or severity of a person’s cancer, which helps doctors determine a prognosis and the best course of treatment.

Common Staging Procedures and Types:

The most common staging is TNM, which designates three aspects of cancer. “T” refers to the size or extent of the tumor; “N” refers to whether cancer cells have spread to nearby lymph nodes and “M” refers to whether the cancer has metastasized.

In addition, numbers are often used to indicate the degree of each aspect, depending on specific cancer types. Most tumors can be described as stage 0, stage I, stage II, stage III or stage IV. Physical exams, imaging procedures, laboratory tests, pathology reports and surgery can all provide information to help determine the stage.

While other testing may be needed, clinical staging determines how much cancer may exist based on a physical exam, imaging and tumor biopsies. The clinical stage is key when deciding the best treatment for an individual diagnosis. It’s also a baseline for comparison when looking at the typical response to treatment for a given type of cancer.

Pathological or surgical staging relies on what is learned during surgery, either to remove the cancer and nearby lymph nodes or to determine how much cancer is in the body and take tissue samples. The pathological stage gives the health care team more precise information, which is used to predict treatment response and outcomes.

If you are looking for additional information about cancer staging, please speak with your doctor, or visit the cancer staging information page provided by the American Cancer Society.

This is not intended as medical advice to replace the expertise and judgment of your health care team. It is intended to help you and your family make informed decisions, together with your doctor.

Columbus CyberKnife Treats 1,000 Patients and Recognizes Four Years of Service

CCKWe recently reached an important milestone with the treatment of our 1,000th patient. Opened in June 2010 as a service of Mount Carmel St. Ann’s Hospital, our center marks four years of operation as the area’s only CyberKnife® treatment provider and one of only four in Ohio.

“This is a testament to our team’s specialized expertise in stereotactic radiosurgery and the use of advanced technologies like CyberKnife,” says Dr. Douglas Widman, Columbus CyberKnife medical director. “In addition to treating more than 1,000 patients, there have been recent industry updates in treatment guidelines specifically for prostate cancer patients that we hope will extend additional options like CyberKnife to patients facing a diagnosis and treatment decision.”

Prostate, lung and brain tumors are the most commonly treated diseases at our center. The number of prostate cancer patients we see is expected to increase after two recent announcements supporting stereotactic body radiation therapy as a treatment option for prostate cancer.

Earlier this year, the National Comprehensive Cancer Network® released its 2014 Clinical Practice Guidelines in Oncology® which now include SBRT as a treatment option for prostate cancer. Read more about these updates here.

Additionally, the American College of Radiology recently updated its Appropriateness Criteria for early stage prostate cancer indicating that SBRT may help patients diagnosed with the disease.

“When seeking treatment for prostate cancer, men should educate themselves on the treatment options available for their diagnosis. For those who are candidates, SBRT is a nonsurgical alternative with few to no side effects. Some men, particularly those who work or travel regularly, are drawn to these benefits of CyberKnife SBRT,” Dr. Widman says.

CyberKnife technology, in use for more than 20 years in the cancer industry, treats tumors throughout the body with stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT).

Contact our center to learn if you or a loved one could be a candidate for CyberKnife treatment.

This is not intended as medical advice to replace the expertise and judgment of your health care team. It is intended to help you and your family make informed decisions, together with your doctor.

Benefits of CyberKnife Treatment for Prostate Cancer Patients

CCKColumbus CyberKnife strives to be a resource for prostate cancer patients looking to find out more about how CyberKnife® treatment can benefit them. Below are some common questions and answers about the CyberKnife technology.

What sets CyberKnife apart from other treatment options?

A major advantage of this technology is its ability to
 offer patients a noninvasive treatment option without impeding on their lifestyle. CyberKnife treats prostate cancer patients in five or fewer sessions, allowing patients to return to their normal routines immediately following each session. The accuracy of treatment also reduces side effects associated with other forms of treatment for prostate cancer.

How is SBRT with CyberKnife different from conventional radiation therapy? 


CyberKnife has the ability to directly target the prostate while compensating for patient and prostate movement during treatment. This technology minimizes radiation exposure to surrounding healthy tissue. Since CyberKnife treatment for prostate cancer is completed within five sessions over a period lasting one to two weeks, treatment time is also significantly shorter than traditional radiation therapy, which can last up to eight weeks.

Is SBRT more expensive than other treatment options? 


No. A study titled “Cost-Effectiveness Analysis of SBRT Versus IMRT” compared the cost of SBRT and IMRT for treatment of low- to intermediate-risk prostate cancer. The study revealed that on average the cost of SBRT was nearly $14,000 less than IMRT. You can learn more about the study here.

CyberKnife offers several benefits for patients, particularly those related to quality of life issues that may be dramatically impacted by conventional surgery. To find out if you are a candidate for CyberKnife treatment, contact our center.

This is not intended as medical advice to replace the expertise and judgment of your health care team. It is intended to help you and your family make informed decisions, together with your doctor.

American College of Radiology Updates Guidelines, Stereotactic Body Radiation Therapy For Prostate Cancer Viewed Favorably

CCK-ACRThe American College of Radiology recently updated its Appropriateness Criteria (guidelines) for early stage prostate cancer indicating that stereotactic body radiation therapy (SBRT) may help patients diagnosed with prostate cancer.

According to the report, “There are growing data to suggest that hypofractionation on a dose-per-fraction less than 3.0 Gy per fraction is reasonably safe and efficacious, and although the early results from hypofractionation/SBRT studies at dose-per-fraction greater than 4.0 Gy appear promising, these approaches should continue to be used with caution until more mature, ongoing phase II and III randomized controlled studies have been completed.”

SBRT for prostate cancer involves five or fewer treatment sessions, minimizing disruption to men’s normal routines and lifestyles. Click here for a complete copy of the guidelines.

The American College of Radiology is made up of 36,000 members including radiologists, radiation oncologists, medical physicists, interventional radiologists, nuclear medicine physicians and allied health professionals.

This is not intended as medical advice to replace the expertise and judgment of your health care team. It is intended to help you and your family make informed decisions, together with your doctor.

Columbus CyberKnife Recognizes Four Years of Service to Cancer Patients

cck logo copyThis month, Columbus CyberKnife celebrates four years of service to the area’s cancer patient community. Since opening in 2010, Columbus CyberKnife, in partnership with Mount Carmel St. Ann’s Hospital, has treated more than 900 patients. While lung and brain tumors are frequently treated diseases, we also treat cancer of the prostate, spine, pancreas, kidney and liver, as well as other medical conditions like trigeminal neuralgia and arteriovenous malformations.

CyberKnife® is an advanced technology that performs stereotactic body radiation therapy (SBRT), a nonsurgical method of treating tumors with high-dose radiation in five or fewer procedures. The capabilities of our center’s advanced tracking system allow for greater accuracy, quicker treatment times for patients and better avoidance of healthy tissue during treatment.

As the first and only CyberKnife treatment provider in Columbus, our dedicated staff works to stay on the leading edge of cancer care through clinical research and a recent upgrade of our cancer treatment technology to the next-generation CyberKnife® 10.0 system.

This is not intended as medical advice to replace the expertise and judgment of your health care team. It is intended to help you and your family make informed decisions, together with your doctor.

Men’s Health Week: Tips for Maintaining Prostate Health

CCK-Mens Health 1392063621508Men’s Health Week is celebrated June 9-15, the week leading up to and including Father’s Day. According to the Men’s Health Week website, the purpose of this week is to “heighten the awareness of preventable health problems and encourage early detection and treatment of disease among men and boys.”

In honor of Men’s Health Week, Columbus CyberKnife recommends men take the following steps to maintain a healthy prostate:

  • Stick to a low-fat diet
  • Avoid cigarette smoke and tobacco products
  • Exercise on a regular basis
  • Get an annual prostate check-up after reaching the age of 40
  • Reduce the amount of alcohol and caffeine intake
  • Maintain a regular sex schedule

Additional information about prostate health can be found on the Prostate Health Guide website.

Our center treats prostate cancer with a nonsurgical procedure called stereotactic body radiation therapy using CyberKnife® technology. If you or a loved one has been diagnosed with prostate cancer, contact our center to learn if you are a candidate for CyberKnife treatment.

This is not intended as medical advice to replace the expertise and judgment of your health care team. It is intended to help you and your family make informed decisions, together with your doctor.

Prostate Cancer Treatment Options

The right treatment option for prostate cancer can vary greatly depending on a number of factors, including the age, health and lifestyle of the patient. The stage, grade of the tumor and Gleason score are also important factors.

To learn more about prostate cancer treatment options and how CyberKnife treats prostate cancer in five or fewer treatments, view the presentation below.

This is not intended as medical advice to replace the expertise and judgment of your health care team. It is intended to help you and your family make informed decisions, together with your doctor.